U.S. Embassy Montevideo - Archives

U.S. launches new web resource for World TB Day, March 24

Site highlights ongoing research

Posted: March 24, 2005

The National Institute of Allergy and Infectious Diseases (NIAID) has launched a new website to focus on the range of research into tuberculosis being conducted by the agency.

The agency unveils the new information source in time for World TB Day March 24, an occasion that draws attention to a curable disease that still kills 2 million people a year, according to international estimates.

People who suffer from the weakened immune system characteristic of AIDS are especially vulnerable to TB, and the disease is the number one cause of death in that population.

The new NIAID Web feature is available at http://www2.niaid.nih.gov/newsroom/FocusOn/tb/default.htm

The text of the NIAID press announcement follows:

(begin text)

National Institute of Allergy and Infectious Diseases (NIAID)

Tuesday March 22, 2005

Updated Focus on TB Web Site Launched for World TB Day

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an updated Web feature called “Focus on TB.” The site highlights research being done in NIAID’s labs in Bethesda, MD, and by NIAID-supported researchers across the country and around the world. Advances in drug development, new ways to diagnose TB quickly, and promising vaccine approaches are described.

Visit the site at http://www2.niaid.nih.gov/newsroom/FocusOn/tb/default.htm

World TB Day, each March 24th, is an occasion to reflect on the grave problem that TB still poses throughout the world and to acknowledge advances in diagnosing, treating and preventing the disease. The World Health Organization estimates that one-third of the world’s population is infected by Mycobacterium tuberculosis, the bacterium that causes TB, and that as many as two million people die of TB each year.

March 24th is the anniversary of the date, in 1882, that German bacteriologist Robert Koch astonished the scientific world by announcing that he had discovered the cause of TB. At the time, TB rampaged through Europe and the Americas, killing one in every seven people. Koch’s discovery raised hopes that this terrible killer might be vanquished.

NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism.

NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.

For more information or to schedule an interview with one of our expert researchers, please contact the NIAID Office of Communications and Public Liaison at (301) 402-1663.

News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at <http://www.niaid.nih.gov/>.

The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

(end text)


/ Return to:  Home l Previous page
Jump to:  2003  2004  2005  2006  2007  2008  2009  2010  |  Official Website